Anti-CNTN1 antibodies have been found in individuals with chronic inflammatory demyelinating polyneuropathy (CIDP), which raises the possibility that the autoimmune response in MN and the pathophysiology of the underlying neurological lesion are linked [131]. This evidence concerns the gene CNTN1 and chronic inflammatory demyelinating polyradiculoneuropathy.